Travere Therapeutics Inc.
TVTX | NASDAQ
$62.86
+$0.10 (+0.16%)
At close: Sep 21, 2026, 4:00 PM ET
$61.61
-$1.25 (-1.99%)
Pre-market:
Sep 22, 2026, 7:47 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 591.33M | 536.2M | 490.73M | 435.83M | 333.87M | 273.53M | 233.18M | 203.45M | 177.64M | 155.72M | 171.34M | 182.15M | 173.13M | 195.1M | 186.6M | 187.98M | 228.12M | 228.57M | 227.49M | 221.22M | 204.15M | 197.96M |
Cost of Revenue | 33.08M | 32.43M | 10.34M | 10.34M | 10.38M | 21.26M | 18.09M | 31.95M | 31.62M | 20.66M | 24.28M | 9.59M | 15.57M | 16.17M | 13.18M | 13.35M | 7.68M | 7.28M | 6.78M | 6.96M | 6.56M | 6.4M |
Gross Profit | 558.25M | 503.77M | 480.39M | 425.49M | 323.49M | 252.27M | 215.09M | 171.5M | 146.03M | 135.06M | 147.06M | 172.56M | 157.56M | 178.93M | 173.41M | 174.63M | 220.44M | 221.29M | 220.71M | 214.26M | 197.59M | 191.56M |
Operating Income | -40.46M | -57.06M | -62.82M | -91.13M | -172.21M | -226.61M | -323.17M | -345.28M | -381.71M | -418.61M | -359.67M | -343.68M | -333.7M | -295.2M | -271.96M | -252.3M | -201.4M | -171.27M | -161.77M | -233.13M | -220.85M | -208.65M |
Interest Income | 11.58M | 11.51M | 12.72M | 13.92M | 14.45M | 15.58M | 17.82M | 21.17M | 23.45M | 24.15M | 21.77M | 17.73M | 13.99M | 9.64M | 6.28M | 3.4M | 1.66M | 1.86M | 1.99M | 2.35M | 3.11M | 3.44M |
Pretax Income | -67.07M | -44.81M | -49.27M | -88.55M | -169.1M | -225.93M | -320.51M | -348.7M | -383.09M | -415.39M | -376.11M | -353.34M | -348.03M | -313.14M | -292.58M | -278.39M | -230.06M | -202.05M | -179.68M | -250.21M | -237.14M | -224.18M |
Net Income | -43.46M | -21.42M | -25.55M | -88.54M | -169.06M | -226.71M | -321.55M | -351.45M | -145.91M | -161.13M | -111.4M | -87.05M | -307.44M | -288.84M | -278.48M | -264.23M | -230.22M | -202.2M | -180.09M | -250.14M | -237.05M | -224.11M |
Selling & General & Admin | 364.51M | 344.62M | 337.2M | 305.01M | 284.17M | 262.39M | 253.77M | 237.01M | 239.19M | 252.96M | 260.98M | 271.17M | 255.79M | 240.56M | 215.11M | 194.26M | 177.91M | 159.89M | 149.88M | 143.55M | 139.43M | 139.44M |
Research & Development | 227.14M | 216.22M | 206.01M | 210.21M | 210M | 214.97M | 282.7M | 279.38M | 288.29M | 300.46M | 245.74M | 247.23M | 243.78M | 236.97M | 233.67M | 235.61M | 226.87M | 218.99M | 210.33M | 186.55M | 170.49M | 149.47M |
Other Expenses | 7.06M | n/a | n/a | 1.4M | 1.53M | 1.53M | 1.79M | 382K | 259K | 259K | 87K | -2.07M | -8.23M | -3.32M | -3.38M | -2.92M | 17.1M | 13.7M | 22.26M | 117.3M | 108.52M | 111.3M |
Operating Expenses | 598.71M | 560.83M | 543.21M | 516.62M | 495.7M | 478.88M | 538.26M | 516.77M | 527.74M | 553.68M | 506.73M | 516.24M | 491.26M | 474.13M | 445.37M | 426.92M | 421.85M | 392.56M | 382.47M | 447.39M | 418.44M | 400.21M |
Interest Expense | 9.48M | 10.19M | 10.75M | 11.27M | 11.3M | 11.24M | 11.18M | 11.19M | 11.23M | 11.29M | 11.34M | 11.41M | 11.42M | 11.55M | 11.21M | 13.39M | 15.46M | 17.34M | 20.14M | 19.83M | 19.7M | 19.48M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -10.35M | -10.35M | -21.2M | -21.2M | -10.86M | -4.56M | 6.3M | 6.3M | 6.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 631.79M | 593.26M | 553.55M | 526.96M | 506.08M | 500.14M | 556.09M | 548.46M | 559.1M | 574.08M | 531.01M | 525.83M | 506.83M | 490.3M | 458.55M | 440.27M | 429.52M | 399.84M | 389.26M | 454.35M | 425M | 406.61M |
Income Tax Expense | 605K | 829K | 988K | -5K | -97K | -32K | 120K | 260K | 356K | 336K | 223K | 218K | 351K | 339K | 313K | 254K | 152K | 148K | 409K | -66K | -86K | -70K |
Shares Outstanding (Basic) | 93.48M | 91.87M | 90.29M | 89.23M | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.41M | 60.57M | 56.27M |
Shares Outstanding (Diluted) | 93.48M | 91.87M | 90.29M | 102.62M | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.8M | 60.57M | 56.27M |
EPS (Basic) | -0.45 | -0.22 | -0.29 | -1.05 | -2.04 | -2.81 | -4.10 | -4.55 | -4.84 | -5.06 | -4.57 | -4.42 | -4.52 | -4.44 | -4.37 | -4.18 | -3.68 | -3.27 | -3.03 | -4.56 | -4.41 | -4.35 |
EPS (Diluted) | -0.49 | -0.26 | -0.33 | -1.09 | -2.04 | -2.81 | -4.10 | -4.55 | -4.84 | -5.06 | -4.57 | -4.42 | -4.52 | -4.44 | -4.37 | -4.18 | -3.68 | -3.27 | -3.03 | -4.56 | -4.41 | -4.35 |
EBITDA | 1.54M | 38.54M | 22.22M | -22.58M | -107.65M | -168.21M | -265.77M | -294.2M | -328.31M | -359.95M | -320.96M | -300.66M | -300.67M | -268.49M | -250.71M | -237.6M | -185.49M | -157.08M | -132.92M | -203.17M | -191.67M | -179.69M |
EBIT | -57.59M | -34.62M | -38.52M | -77.28M | -157.8M | -214.69M | -309.33M | -337.51M | -371.86M | -404.11M | -364.78M | -341.93M | -336.61M | -301.6M | -281.36M | -265M | -214.61M | -184.71M | -159.54M | -230.37M | -217.43M | -204.69M |
Depreciation & Amortization | 59.14M | 73.15M | 60.74M | 54.7M | 50.15M | 46.48M | 43.56M | 43.32M | 43.55M | 44.15M | 43.82M | 41.27M | 35.95M | 33.11M | 30.65M | 27.4M | 29.12M | 27.64M | 26.62M | 27.2M | 25.77M | 25M |
Add to Watchlist
Select watchlists to add or remove TVTX